How FDA approval of over-the-counter Narcan sales affects the opioid crisis

This week, the FDA approved nationwide over-the-counter sales of Narcan, the brand name version of the generic overdose reversal drug naloxone. Overdoses are the leading cause of accidental death in the U.S., driven in large part by opioid use. Dr. Andrew Kolodny, co-director of opioid policy research at the Heller School at Brandeis University, joins John Yang to discuss.
Stream your PBS favorites with the PBS app: to.pbs.org/2Jb8twG
Find more from PBS NewsHour at www.pbs.org/newshour
Subscribe to our CZcams channel: bit.ly/2HfsCD6
Follow us:
Facebook: www.pbs.org/newshour
Twitter: / newshour
Instagram: / newshour
Subscribe:
PBS NewsHour podcasts: www.pbs.org/newshour/podcasts
Newsletters: www.pbs.org/newshour/subscribe